If the null hypothesis is that bisantrene is neither cardioprotective nor anticancer, rejecting that means that bisantrene is either cardioprotective or anticancer or both.
But we want it to be both. The one but not the other csses don't help.
So there have to be two separate null hypotheses.
I think this affects the required sample size.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
RAC
race oncology ltd
Add to My Watchlist
1.22%
!
$1.24

Cardioprotection thread, page-56
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.24 |
Change
0.015(1.22%) |
Mkt cap ! $215.4M |
Open | High | Low | Value | Volume |
$1.26 | $1.26 | $1.23 | $106.2K | 85.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 11900 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 819 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11900 | 1.220 |
2 | 2823 | 1.215 |
2 | 5223 | 1.210 |
1 | 600 | 1.205 |
5 | 30774 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 819 | 1 |
1.260 | 10000 | 1 |
1.280 | 4060 | 1 |
1.300 | 9431 | 2 |
1.310 | 2360 | 1 |
Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online